Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak

Active
OC-2026-135667Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → Food And Drug AdministrationView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Liverpool, MD, GBR

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Food And Drug Administration
Contacts2 people available
OfficeRockville, MD, 20841, US
Organization / Agency
Department Of Health And Human Services → Food And Drug Administration
View Agency Profile
Office AddressRockville, MD, 20841, US
Contacts
Ryan Alexander
contact@example.gov
Craig Wright
contact@example.gov

Full Description

Show more

Procurement Type: Sole Source Simplified Acquisition Procedures (SAP) Purchase Order for Commercial Items


Authority: FAR Part 6.103-1, Only One Responsible Source


Subject: Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak


Description: The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price purchase order to The University of Liverpool for the Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak, in accordance with the authority under FAR Part 6.103-1, Only One Responsible Source. This procurement is being conducted under simplified acquisition procedures in accordance with FAR Part 12 (RFO). The NAICS Code for this action is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).


The primary objective of this requirement is to obtain critical reagents such as procure reference standards and internal standards to perform bioanalytical method development and sample analysis to determine the quantification of CYP enzyme substrates/metabolites and transporter substrates in hepatocyte experiments.


Responses:


Responses to this notice should be sent to Ryan Alexander at ryan.alexander@fda.hhs.gov by 5:00 pm July 29, 2026. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Humanized Antibody Library Screening and Transferrin Receptor DevelopmentThe contract involves the customized screening of a humanized antibody library to develop a functional transferrin receptor, encompassing molecular design, in vitro selection, and optimization of binding affinity and specificity. The work requires advanced techniques in antibody engineering to identify and refine candidates capable of high-affinity, selective interaction with the transferrin receptor, with the goal of producing a therapeutically viable candidate. The scope includes iterative cycles of library screening, functional characterization, and structural optimization to enhance target binding while minimizing off-target interactions, ensuring the final product meets stringent performance benchmarks. This subcontract is issued under the NAICS code 541714 for research and development in the biological sciences and is associated with the National Institutes of Health through the Department of Health and Human Services. The place of performance is in Bethesda, Maryland, with a deadline for proposals set for July 31, 2026. The contract is expected to support biomedical innovation targeting receptor-mediated delivery systems and requires expertise in molecular biology, high-throughput screening, and protein engineering. No specific set-aside provisions are indicated, and the work is open to qualified subcontractors capable of delivering scalable, data-driven antibody development solutions within the defined timeline.
National Institutes Of Health Olao

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
Recombinant Antibody Discovery & Engineering ServicesThe contract involves the discovery, humanization, and engineering of single domain antibodies designed to penetrate the blood-brain barrier using phage and yeast display platforms. This effort includes advanced antibody optimization through affinity maturation to enhance binding strength and specificity, as well as comprehensive stability testing to ensure functional integrity under physiological conditions. The work is scientifically focused on developing recombinant antibody formats capable of crossing the blood-brain barrier, a critical step for therapeutic applications targeting neurological diseases. This subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, is classified under NAICS code 541714 for research and development in the physical, engineering, and life sciences. The opportunity was posted on July 24, 2026, with a response deadline of August 3, 2026. Performance is expected to take place in Bethesda, Maryland, 20892. The project does not specify a set-aside type or point of contact details, and the full solicitation can be accessed via the provided SAM.gov link for additional procedural or submission guidelines.
National Institutes Of Health Olao

POSTED

about 20 hours ago

DEADLINE

in 9 days
View Details
NAICS: 541714
New
Federal
Develop and Validate Transferrin ReceptorThe National Institutes of Health, under the Department of Health and Human Services, has issued a presolicitation notice for the development and validation of a transferrin receptor, identified by solicitation number 75N98026Q00866. This opportunity is open for responses until July 31, 2026, and was posted on July 24, 2026, with no set-aside provisions applied, making it open to all eligible entities. The work will be performed in Bethesda, Maryland, and falls under the NAICS code 541714, which corresponds to research and development in the physical, engineering, and life sciences. The primary point of contact for inquiries is Towanda Daniels, reachable via email at danielt@mail.nih.gov. Interested parties are directed to the official SAM.gov workspace link for further details and submission guidelines. The contract aims to support advanced scientific research focused on the transferrin receptor, likely to advance biomedical applications or therapeutic technologies. All proposals must adhere to the requirements outlined in the notice of intent, and submissions should be prepared with consideration for the technical scope, timeline, and performance standards expected by the NIH Office of Laboratory Animal Welfare. The contract is structured to enable innovation in molecular biology or drug delivery systems involving receptor targeting, with performance expected within the confines of federal research protocols and compliance standards.
National Institutes Of Health Olao

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
Humanized single domain antibodies for therapeutic brain delivery​The National Institutes of Health Office of Extramural Research, under the Department of Health and Human Services, has issued a presolicitation for the development of humanized single domain antibodies designed for therapeutic delivery across the blood-brain barrier. The project, identified by solicitation number 75N98026Q00867, aims to advance novel antibody technologies capable of targeting brain-specific pathologies with enhanced precision and efficacy. All responses are due by August 3, 2026, and no set-aside provisions are applicable, meaning the opportunity is open to all eligible entities. The performance location is designated as Bethesda, Maryland, with the contract administration handled by the agency’s office at 20892. Primary point of contact for inquiries is Towanda Daniels, reachable via email at danielt@mail.nih.gov. The solicitation was posted on July 24, 2026, and all potential offerors are directed to the designated SAM.gov workspace for additional details and documentation. No NAICS code has been assigned at this stage, and the initiative reflects a strategic effort to enable breakthrough treatments for neurological disorders through innovative biotherapeutic platforms. Applicants must ensure full compliance with the requirements outlined in the attached Notice of Intent.
National Institutes Of Health Olao

POSTED

about 20 hours ago

DEADLINE

in 9 days
View Details
NAICS: 541714
New
Federal
Procurement of lateral flow (LFA) strips for the rapid HIV nucleic acid diagnostic testThe Centers for Disease Control and Prevention is soliciting bids for the procurement of 4,000 lateral flow strips intended for use in a rapid HIV nucleic acid diagnostic test under a firm-fixed-price contract, issued as a Request for Quote in accordance with FAR Subpart 12 for commercial items. The solicitation number is 75D30126Q79099, with a performance period of August 1, 2026, to December 31, 2026, and an option to extend services for up to six additional months. Proposals must be submitted electronically to Eugene Gutierrez at zvm0@cdc.gov no later than 3:00 P.M. Eastern Standard Time on Friday, July 24, 2026, with no telephonic or paper submissions accepted. The place of performance is the CDC facility at 1600 Clifton Road, Building 17, Atlanta, GA 30329-4018. Offerors must be registered in the System for Award Management at the time of submission and are required to comply with all applicable FAR clauses, including 52.212-1 and 52.212-4, along with deviations such as those addressing trafficking in persons, contractor employee whistleblower rights, sustainable products and services, Buy American Act alternatives for Israeli and Korean end products, and prohibitions on unauthorized information sharing. Technical evaluation is the predominant factor in award, emphasizing experience with biomedical devices, FDA approval processes, and prior work with lateral flow technology, with price considered secondary. The contractor must deliver 200 prototype strips and 4,000 final units meeting stringent performance standards: ≤0.5% false positive rate and ≤1% false negative rate using CDC’s LAMP reaction, and must ensure full compatibility with CDC’s mass production protocols. All deliverables must conform to Section 508 accessibility requirements, including WCAG 2.0 Level AA, and vendors must provide a Voluntary Product Accessibility Template or HHS conformance checklist. The contract imposes strict security and confidentiality obligations, including mandatory non-disclosure agreements for all employees accessing sensitive information, identification protocols to distinguish contractor personnel from government staff, and prohibitions against retaining or disseminating federal records or Privacy Act data. Subcontractors must be bound by the same requirements, and all payments must be processed via the Treasury’s Invoice Processing Platform using an ACH Vendor Enrollment
CDC Office Of Acquisition Services

POSTED

about 20 hours ago

DEADLINE

in 4 days
View Details
NAICS: 541714
New
Federal
Illumina Reagent KitsThe United States Department of the Naval Medical Research Command intends to award a sole source contract to Illumina, Inc. of San Diego, California, for the purchase of Illumina Reagent Kits. This procurement is not a competitive solicitation, but responses received will be considered if submitted. The action is classified under NAICS code 541714 and will be conducted under FAR Part 12 guidelines for commercial items. All vendors must be registered in the Systems for Award Management (SAM) and possess a Unique Entity Identification Number (UEI) to be eligible for award, with SAM registration available free of charge through sam.gov or by calling (866) 606-8220. The contract is identified by solicitation number 1301397256, posted on July 23, 2026, with a response deadline of August 7, 2026. The contracting office is located in Silver Spring, Maryland, with performance expected in Frederick, Maryland. Primary point of contact is Shamai Carter, reachable at shamai.m.carter.civ@health.mil, with Nataki Johnson as the secondary contact.
Naval Medical Research Center

POSTED

2 days ago

DEADLINE

in 14 days
View Details
NAICS: 541714
New
Federal
Battlefield Pain Management – AnalgesicThis solicitation under the prototype Other Transaction Authority (10 U.S.C. 4022) seeks the development of a single-use analgesic product for acute moderate to severe battlefield pain, with the ultimate goal of obtaining FDA approval. The product must be a combination drug-device system—such as a nasal spray or autoinjector—that is rapid to administer, compact for individual carry, and stable under extreme environmental conditions, capable of withstanding temperature excursions between -25°C and 45°C without refrigeration and maintaining a 2-3 year shelf life at controlled room temperature. It must comply with USP <659> packaging and storage standards, adhere to 21 CFR Part 820 quality system regulations for labeling and control, and meet strict physiological limits including no more than a 20% reduction in baseline blood pressure, heart rate, or blood clotting ability. The product must be classified as a DEA Schedule II or higher controlled substance and must not require special handling for humidity, pressure, or temperature, verified through MIL-STD-810 testing. The effort spans an estimated eight-year period, divided into three sequential objectives: three years for Chemistry, Manufacturing, and Controls (CMC) and stability studies; two years for non-clinical enabling studies; and three years for clinical trials and human factors testing, including potential Emergency Use Authorization (EUA) submission. Deliverables include detailed regulatory documentation, study strategies, interim and final reports, regulatory meeting minutes, protocol approvals from IACUC and ORRC, and full compliance with Controlled Unclassified Information (CUI) marking and data handling protocols. The contract does not fall under FAR or DFARS, but incorporates selected clauses for electronic payment submission, government property management, and termination for convenience. Proposals must be submitted in three volumes—Technical, Management, and Administrative and Cost—with the technical volume limited to 20 pages plus an unlimited attachment for the Statement of Work. A key eligibility requirement is a pass/fail gate: the proposal must demonstrate participation of at least one nontraditional defense contractor or nonprofit research institute, or that all significant participants are small businesses or nontraditional contractors, or that at least one-third of the total project cost is funded by non-federal sources. The proposal deadline has been extended to August 14, 2026, with all submissions required via email in searchable PDF format, compatible with Microsoft Office and Adobe Acrobat, and free of malware, passwords, or hyperlinks.
Defense Health Agency

POSTED

2 days ago

DEADLINE

in 21 days
View Details
NAICS: 541714
New
Federal
Development of Light-Responsive Artificial Cells using Plant-Based Photoreceptor SystemsThe United States Army Corps of Engineers Engineer Research and Development Center Construction Engineering Research Laboratory is seeking to develop light-responsive artificial cells by integrating plant-derived UVR8 photoreceptor systems into synthetic biology platforms, using high-throughput protein engineering and AI-assisted structural refinement to create programmable, pseudo-living systems activated by environmental light stimuli. The project aims to advance foundational science in synthetic biology by leveraging Bioconscientia, LLC’s uniquely specialized expertise in UVR8 photoreceptor technology, which enables precise sensing of UV-B light in a manner unmatched by other entities. Due to the highly specialized nature of the required research and Bioconscientia’s irreplaceable knowledge of existing experimental data and technical pathways, the government intends to award a sole-source contract to this vendor under RFO FAR 12.102(a), with an anticipated award date of September 30, 2026. This presolicitation notice, issued under FAR Part 5.101(a) with solicitation number W9132T26QA015 and NAICS code 541714, does not constitute a formal request for proposals or a competitive procurement, nor is it a set-aside. Interested parties may submit capability statements to CERL-CT-QUOTES@USACE.ARMY.MIL by July 31, 2026, to be reviewed for potential technical equivalency, but submission does not guarantee a change to the government’s acquisition strategy. The government retains full discretion to proceed with sole-source award regardless of responses received. All work will be performed in Champaign, Illinois, and the primary point of contact for submissions is Lurline L. Simmons, with Andrea J. Thomas serving as the contracting officer. No telephone inquiries will be accepted.
W2R2 Construction Engrg Labor

POSTED

3 days ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
AI/ML and Data Analytics for Cardiovascular Device Validation
FDA Office Of Acq Grant Svcs

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is soliciting collaborative participation through a continuous, open Participant Basic Agreement (PBA) under the HEALER portfolio to advance next-generation, threat-agnostic host-directed therapeutics designed to enhance physiological resilience against CBRN threats. This initiative targets five critical biological systems—neurological protection, respiratory stabilization, immune modulation, hematologic and vascular function, and cellular stress and repair pathways—with the goal of developing dual-use medical countermeasures that serve both military and civilian critical care needs. The program invites two categories of collaborators: therapeutic developers with candidates that modulate host response mechanisms and drug development support providers including CROs and CDMOs with capabilities in preclinical testing, clinical trial execution, cGMP manufacturing, regulatory strategy, and advanced modeling. Submission requires a white paper of no more than five pages excluding a cover page, detailing product mechanism of action, efficacy data from validated animal models, regulatory status such as IND experience and clinical trial history, manufacturing capacity and scale-up plans, and company profile for therapeutic developers, or core capabilities and infrastructure for service providers. All participants must express willingness to collaborate with other PBA holders to foster an integrated development ecosystem. The solicitation, issued under statutory authority of 10 U.S.C. §§4021–4023, operates outside the Competition in Contracting Act and does not follow traditional procurement or evaluation frameworks, eliminating standard contract clauses, formal evaluation factors, pricing structures, or submission deadlines. Instead, awards are made at the government’s discretion through a non-traditional acquisition mechanism designed to accelerate innovation. Technical and administrative inquiries are directed to Hunter Robinson and Alexander Mayatte at the U.S. Army’s Aberdeen Proving Ground, Maryland office. Participation prerequisites include current registration in the System for Award Management (SAM), compliance with FDA regulatory pathways, and adherence to cGMP standards for manufacturing. While no specific delivery dates, FOB terms, inspection criteria, or cost estimates are defined, performance is expected to align with the mission of CPE CBRND to enable the Joint Force to operate effectively in CBRN-contested environments. Intellectual property considerations, teaming arrangements, and the scalability of therapeutic candidates are central to selection, with no socioeconomic or size status certifications required. The structure prioritizes agility, collaboration, and cross-sector innovation over rigid compliance, enabling a dynamic pipeline of medical countermeasures capable of addressing evolving biological threats through sustained host resilience.
W6QK Acc-Apg

POSTED

4 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
Non-Optical Methods for High Speed Protein ControlDARPA’s Biological Technologies Office is seeking innovative solutions through the ERIS Marketplace to develop a new class of rapidly switchable, non-optogenetic protein domains capable of enabling real-time, massless control of cellular processes. The goal is to create a robust, modular molecular tool that responds to non-optical external signals such as magnetic fields or focused ultrasound, allowing precise regulation of protein function across cell membranes without relying on light or chemicals. Proposed solutions must achieve activation and deactivation kinetics of no more than two seconds, demonstrate reliable performance through at least 300 repetitive cycles in living cells, and function effectively in both split-protein dimerization and allosteric conformational configurations. This effort explicitly excludes any modifications or enhancements to existing optogenetic, light-based, or chemical systems. The anticipated contract value is $400,000 for a 12-month performance period, with awards being made on a rolling basis as solutions are evaluated, and the government reserves the right to issue awards before the December 8, 2026 submission deadline. Proposals must be submitted via the DARPA Connect ERIS Portal as a video that follows the required title format, or existing awardable solutions may be flagged for consideration by emailing ERIS@darpa.mil with specific subject and body requirements. Evaluation will focus on four core areas: a deep understanding of the problem space and current limitations in fields like sonogenetics and magnetogenetics, a significant technical leap in achieving rapid and repeatable protein control, demonstrated expertise in synthetic biology, protein engineering, and biophysics with a proven track record of quantitative in vivo characterization, and the potential of the solution to become a foundational tool in synthetic biology with broad applications in defense-relevant areas such as biomanufacturing, cell-based therapeutics, and biosensing. All submissions are subject to the ERIS assessment process, which serves as a mandatory pass/fail gate—only solutions deemed awardable by this process will be considered for BTO award. The procuring agency is the Department of Defense through DARPA’s Arlington, VA office, and all participants must comply with the ERIS Master Solicitation requirements available via SAM.gov.
Defense Advanced Research Projects Agcy

POSTED

4 days ago

DEADLINE

in 5 months
View Details
NAICS: 541714
New
Federal
Notice of Intent to Sole Source – University of Maryland Medical Center
National Institutes Of Health - Cc

POSTED

4 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Health And Human Services → Food And Drug Administration

Same awarding agency

NAICS: 541380
New
Federal
Technical Calibration and Recalibration Services
Testing Laboratories and Services

POSTED

3 days ago

DEADLINE

in 4 days
View Details
NAICS: 541511
New
Federal
Software Development Kit (SDK) and Integration Support
Custom Computer Programming Services

POSTED

3 days ago

DEADLINE

in 4 days
View Details
NAICS: 334510
New
Federal
Flexible Measurement Probe Supply (Component Level)
Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

3 days ago

DEADLINE

in 4 days
View Details
NAICS: 423490
New
Federal
High-Precision Benchtop Spectroradiometer Supply
Other Professional Equipment and Supplies Merchant Wholesalers

POSTED

3 days ago

DEADLINE

in 4 days
View Details
NAICS: 541618
New
Federal
Project Management and ReportingThe contract titled Project Management and Reporting is an 8(a) Sole Source subcontract awarded by the Food and Drug Administration under the Department of Health and Human Services, aimed at providing comprehensive project management services. The scope includes detailed kick-off planning, ongoing monthly reporting, rigorous timeline tracking, and direct coordination with FDA officials to ensure full compliance with regulatory requirements and contract obligations. All work must be performed in Rockville, Maryland, with a zip code of 20852, and is classified under the NAICS code 541618 for management consulting services. The opportunity was posted on July 22, 2026, and responses are due by August 7, 2026, at 7:00 PM, with no solicitation number provided, indicating direct award under the 8(a) program for small disadvantaged businesses.
Other Management Consulting Services

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 541830
New
Federal
Co-Authoring of Scientific Publications and SummariesThe contract involves collaborating with the Food and Drug Administration and researchers from Harvard to co-author peer-reviewed scientific publications and technical summaries, with responsibilities encompassing writing, editing, formatting, and coordinating internal clearance processes. This subcontract is classified as an 8(a) Sole Source award under NAICS code 541830, indicating it is targeted toward small disadvantaged businesses participating in the Small Business Administration’s 8(a) Business Development program. The work will be performed in Rockville, Maryland, with a place of performance address of 20852, and is tied to the Department of Health and Human Services. The opportunity was posted on July 22, 2026, with a firm deadline for responses set for August 7, 2026, at 7:00 p.m. EDT, and is intended to support the generation of high-quality, scientifically credible content that advances public health knowledge through formal scientific channels.
Media Buying Agencies

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 541690
New
Federal
Specialized Analytical Support for Dietary and Exposure AssessmentsThe contract titled Specialized Analytical Support for Dietary and Exposure Assessments is a sole source 8(a) subcontract issued by the Food and Drug Administration under the Department of Health and Human Services to perform advanced statistical and epidemiological analyses focused on dietary patterns and their links to health outcomes. The work is intended to support FDA research initiatives, requiring expertise in complex data modeling, exposure assessment methods, and population-level health trend analysis to inform regulatory decision-making. The performance location is designated as Rockville, Maryland, with a postal code of 20852, indicating the primary operational base for this effort. The solicitation was posted on July 22, 2026, with a response deadline of August 7, 2026, at 7:00 PM, leaving a narrow window for qualified entities to submit proposals. The North American Industry Classification System code 541690 identifies this as other scientific and technical consulting services, underscoring the specialized nature of the analytical support required. This contract is structured as a subcontract, suggesting it is part of a larger research or procurement framework managed by the FDA. Although no point of contact information is provided, the sole source designation confirms that only an 8(a) certified small business with the requisite expertise in dietary and exposure analytics has been selected for this task, eliminating competitive bidding.
Other Scientific and Technical Consulting Services

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 541611
New
Federal
Longitudinal Dietary Data Extraction from Harvard CohortsThe Food and Drug Administration is seeking a subcontractor to extract longitudinal dietary and exposure data from Harvard-based prospective cohort studies, including the NHS and HPFS, to support research into long-term health outcomes. This effort will involve meticulously retrieving, validating, and organizing dietary intake and lifestyle exposure records from established cohorts to provide high-quality, structured data for FDA’s scientific analyses. The work requires deep familiarity with the structure, variables, and historical context of these cohort studies, as well as the ability to align data extraction protocols with FDA’s research objectives and regulatory standards. The contract is designated as an 8(a) Sole Source subcontract under NAICS code 541611, indicating it is reserved for small disadvantaged businesses. Performance is to be conducted in Rockville, Maryland, with a response deadline of August 7, 2026, and the opportunity was posted on July 22, 2026. The subcontractor must possess the technical capability to handle large-scale observational data while ensuring data integrity, confidentiality, and compliance with federal research guidelines. This engagement supports critical FDA initiatives aimed at understanding the impact of dietary patterns on chronic disease incidence and public health trends over decades.
Administrative Management and General Management Consulting Services

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 423490
New
Federal
Supply of OEM Parts, Consumables & Software UpdatesThe contract covers the ongoing supply of manufacturer-specific parts, consumables, and software or firmware updates essential for the operation and maintenance of the Leco FP928 system, ensuring continuous functionality and compliance with operational standards. This subcontract is tied to the Food and Drug Administration under the Department of Health and Human Services, with performance required at a location in Atlanta, Georgia, zip code 30310. The North American Industry Classification System code 423490 indicates the scope involves wholesale trade of machinery and equipment. The solicitation was posted on July 22, 2026, with responses due by July 29, 2026, at 4:00 PM, establishing a tight window for vendor submissions. While no set-aside type is specified, the contract is structured as a subcontract, implying participation within a larger procurement framework. All deliverables must align precisely with OEM specifications to maintain system integrity, regulatory compliance, and uninterrupted service for the end user.
Other Professional Equipment and Supplies Merchant Wholesalers

POSTED

3 days ago

DEADLINE

in 4 days
View Details
NAICS: 811310
New
Federal
Gold Maintenance & Preventive Service SupportThe contract spans five years and provides a comprehensive Gold Maintenance Plan centered on preventive servicing and emergency support for critical equipment, ensuring continuous operational reliability. Annual preventive maintenance is included alongside emergency repairs, all necessary parts, and timely software updates, with a guaranteed 48-hour response time for urgent service requests to minimize downtime and maintain compliance with operational standards. The agreement is structured as a subcontract under the NAICS code 811310, managed by the Food and Drug Administration under the Department of Health and Human Services, with performance obligations tied to the Atlanta location at zip code 30310. The solicitation was posted on July 22, 2026, with a firm deadline for responses on July 29, 2026, at 4:00 PM, and while no set-aside provisions are specified, the contract is positioned to support essential infrastructure under federal oversight.
Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance

POSTED

3 days ago

DEADLINE

in 4 days
View Details
NAICS: 611430
New
Federal
Technical Training Delivery for Laboratory StaffThe contract involves delivering on-site, hands-on training to up to four personnel from the Food and Drug Administration’s laboratory team on the operation, maintenance, and troubleshooting of the Leco FP928 system, including its software and consumables. The training is designed to ensure proficient and independent use of the equipment, with a focus on practical skills necessary for daily laboratory functions and system reliability. Training will take place at a facility in Atlanta, Georgia, with a zip code of 30310, and is classified as a subcontract under NAICS code 611430, which corresponds to professional and management development training. The opportunity was posted on July 22, 2026, with a response deadline of July 29, 2026, indicating a relatively short window for potential vendors to submit proposals. The work is being procured by the Department of Health and Human Services on behalf of the FDA, highlighting its importance to regulatory and analytical laboratory operations.
Professional and Management Development Training

POSTED

3 days ago

DEADLINE

in 4 days
View Details
NAICS: 334516
New
Federal
Laboratory Equipment Installation & Qualification (IQ/OQ)The contract pertains to the on-site installation, setup, and operational qualification of the Leco FP928 Combustion Protein Analyzer at a facility in Atlanta, Georgia, with a zip code of 30310. The scope includes full Installation Qualification (IQ) and Operational Qualification (OQ) procedures, calibration verification to ensure accuracy and reliability, and the delivery of comprehensive compliance documentation meeting regulatory standards. All activities must be conducted at the designated location, with no flexibility for remote or off-site work, and the provider is expected to ensure the equipment is fully functional, properly calibrated, and compliant with applicable laboratory and regulatory requirements. This subcontract is posted under the NAICS code 334516, relating to laboratory analytical instrument manufacturing, and is managed by the Food and Drug Administration under the Department of Health and Human Services. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2026, at 4:00 PM Eastern Time. The place of performance is fixed in Atlanta, and while specific contact details are not provided, bidders are expected to follow the guidance on the SAM.gov portal link for submission requirements. The work is critical for ensuring the instrument meets quality assurance protocols and remains in compliance with federal laboratory standards.
Analytical Laboratory Instrument Manufacturing

POSTED

3 days ago

DEADLINE

in 4 days
View Details